Hepion Pharmaceuticals, Inc. SEC filings HEPA
Hepion Pharmaceuticals, Inc. has 723 filings in SEC EDGAR's recent list, going back to Aug 8, 2013. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 9, 2026 (material agreement, acquisition or sale of assets, unregistered share sale, officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Apr 8, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Feb 7, 2025 | Dec 31, 2023 |
| 10-K/A | Amended annual report | Jan 13, 2025 | Dec 31, 2023 |
| 10-K/A | Amended annual report | Jun 25, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Apr 16, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Apr 10, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Apr 8, 2022 | Dec 31, 2021 |
| 10-K/A | Amended annual report | Apr 28, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Mar 31, 2021 | Dec 31, 2020 |
| 10-K/A | Amended annual report | Jun 15, 2020 | Dec 31, 2019 |
| 10-K | Annual report | May 14, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Mar 14, 2019 | Dec 31, 2018 |
| 10-KT | Transition report | Mar 26, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Sep 28, 2017 | Jun 30, 2017 |
| 10-K | Annual report | Sep 28, 2016 | Jun 30, 2016 |
| 10-K | Annual report | Sep 25, 2015 | Jun 30, 2015 |
| 10-K/A | Amended annual report | Nov 7, 2014 | Jun 30, 2014 |
| 10-K | Annual report | Sep 29, 2014 | Jun 30, 2014 |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HEPA (OTC), CTRVP (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Red Bank, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1583771
- Former names
- ContraVir Pharmaceuticals, Inc. (until Jul 23, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.